Effectiveness of Structured Myofascial Release

NCT06744608 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2024-12-20

No results posted yet for this study

Summary

The aim of our research is to examine the effects of myofascial release techniques on symptoms in patients with primary dysmenorrhea. With this research, we aim to improve the clinical symptoms, pain and tension of primary dysmenorrhea with a structured manual therapy consisting of myofascial release and sacral mobilization in individuals with primary dysmenorrhea and an educational program that includes changes in daily life. Can Structured Myofascial Release Techniques Reduce Pain and Other Symptoms in Primary Dysmenorrhea? H0: Myofascial release techniques applied to individuals with primary dysmenorrhea have no effect on symptoms. H1: Myofascial release techniques applied to individuals with primary dysmenorrhea have an effect on symptoms.

Conditions

  • Primary Dysmenorrhea

Interventions

OTHER

Structured Myofascial Release

haftada 2 seans 8 hafta boyunca toplam 16 seans uygulama yapıldı

DEVICE

tens (transcutaneous electrical nerve stimulation)

A total of 16 sessions of application were applied to the groups, 2 sessions per week for 8 weeks.

BEHAVIORAL

lifestyle changes

A presentation including lifestyle changes was prepared and training was provided.

Sponsors & Collaborators

  • Medipol University

    lead OTHER

Principal Investigators

  • SERT BUSE · İstanbul Medipol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-27
Primary Completion
2024-12-01
Completion
2024-12-16

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06744608 on ClinicalTrials.gov